Stoneridge Investment Partners’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Stoneridge Investment Partners’s Portfolio BRLI Stock Details BRLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-49,698	Closed	-$2.05M	–	336
2015 Q2	$2.05M	Sell	49,698 -12,647	-20%	-$453K	0.25%	115
2015 Q1	$2.2M	Buy	62,345 +782	+1%	+$26.5K	0.26%	125
2014 Q4	$1.98M	Buy	61,563 +22,708	+58%	+$657K	0.26%	124
2014 Q3	$1.09M	Buy	+38,855	New	+$1.18M	0.16%	152
2013 Q3	–	Sell	-9,633	Closed	-$277K	–	251
2013 Q2	$277K	Buy	+9,633	New	+$265K	0.06%	143

Other funds holding BRLI

SAM

Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

Stoneridge Investment Partners's BRLI Position: Q3 2015 in Review

Stoneridge Investment Partners sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 49,698 shares — an estimated $2.05M sold.

Stoneridge Investment Partners first reported a position in BRLI in Q2 2013 and held it in 5 quarters. The position peaked at $2.2M in Q1 2015. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

Stoneridge Investment Partners reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
Stoneridge Investment Partners sold 49,698 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $2.05M.
Stoneridge Investment Partners first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 5 quarters.
Stoneridge Investment Partners's BIO-REFERENCE LABS INC-NEW- position peaked at $2.2M in Q1 2015.
1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on Stoneridge Investment Partners's 13F filing for Q3 2015, filed 26 Oct 2015.